600165 ST寧科生物
按盤價 
3.710 +0.100 (+2.770%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1,247.571 | -630.484 | -141.042 | -31.724 | -19.240 |
| 總資產報酬率 ROA (%) | -7.624 | -21.032 | -14.906 | -6.409 | -5.002 |
| 投入資產回報率 ROIC (%) | -48.350 | -55.433 | -24.808 | -9.274 | -6.613 | 邊際利潤分析 |
| 銷售毛利率 (%) | -25.359 | -19.539 | -34.621 | 0.084 | -32.934 |
| 營業利潤率 (%) | -70.734 | -162.216 | -172.692 | -39.561 | -74.861 |
| 息稅前利潤/營業總收入 (%) | -82.057 | -125.849 | -130.799 | -25.362 | -62.638 |
| 淨利潤/營業總收入 (%) | -87.930 | -167.102 | -180.357 | -40.912 | -76.166 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 58.433 | 50.916 | 60.907 | 92.316 | 93.760 |
| 價值變動淨收益/利潤總額(%) | 0.000 | 14.378 | -6.631 | -14.389 | -21.262 |
| 營業外收支淨額/利潤總額(%) | 19.675 | 3.266 | 4.302 | 1.567 | 0.459 | 償債能力分析 |
| 流動比率 (X) | 0.202 | 0.113 | 0.106 | 0.153 | 0.289 |
| 速動比率 (X) | 0.120 | 0.059 | 0.055 | 0.087 | 0.155 |
| 資產負債率 (%) | 97.818 | 88.917 | 89.665 | 75.079 | 67.822 |
| 帶息債務/全部投入資本 (%) | 119.654 | 67.900 | 59.728 | 48.212 | 40.677 |
| 股東權益/帶息債務 (%) | -21.135 | 33.560 | 10.189 | 54.847 | 77.844 |
| 股東權益/負債合計 (%) | -4.374 | 3.726 | 3.739 | 22.748 | 34.358 |
| 利息保障倍數 (X) | -13.668 | -3.008 | -2.634 | -1.710 | -4.984 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 70.788 | 64.586 | 56.537 | 15.543 | 47.113 |
| 存貨周轉天數 (天) | 88.094 | 86.287 | 95.595 | 75.511 | 122.267 |
| 備註： | 即時報價更新時間為 10/09/2025 11:26 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
